QUALCOMM Aktie
WKN: 883121 / ISIN: US7475251036
05.11.2014 23:46:51
|
Alnylam Pharma Loss Narrower Than Street
(RTTNews) - Alnylam Pharmaceuticals Inc (ALNY) Wednesday reported third-quarter net loss of $44 million or $0.58 per share compared with a loss of $29.7 million or $0.48 per share last year.
Revenues from collaborators for the quarter were $11 million compared with $9 million in the prior year.
Analysts polled by Thomson Reuters estimated a loss of $0.63 per share on revenues of $8.9 million for the quarter. Analysts' estimates typically exclude special items.
For the full year 2014, the now company expects its cash, cash equivalents and marketable securities balance to be greater than $860 million compared with prior guidance of $825 million.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu QUALCOMM Inc.mehr Nachrichten
11.04.25 |
Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated (EQS Group) | |
10.04.25 |
Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated (EQS Group) | |
09.04.25 |
NASDAQ Composite Index-Titel QUALCOMM-Aktie: So viel hätten Anleger mit einem Investment in QUALCOMM von vor einem Jahr verloren (finanzen.at) | |
08.04.25 |
Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated (EQS Group) | |
07.04.25 |
Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated (EQS Group) | |
04.04.25 |
Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated (EQS Group) | |
03.04.25 |
Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated (EQS Group) | |
02.04.25 |
NASDAQ Composite Index-Wert QUALCOMM-Aktie: So viel Gewinn hätte ein QUALCOMM-Investment von vor 10 Jahren eingefahren (finanzen.at) |
Analysen zu QUALCOMM Inc.mehr Analysen
02.05.24 | QUALCOMM Neutral | UBS AG |
Aktien in diesem Artikel
QUALCOMM Inc. | 117,48 | -1,03% |
|